Navigation Links
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Date:9/21/2007

appetite, the amount of food eaten, and body weight. These are not all the side effects with BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For complete safety profile and other important prescribing considerations, visit http://www.BYETTA.com.

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over 1,700 employees nationwide.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help health care professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains forward-looking statements about Amylin and Lilly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that exenatide and the revenu
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov. 25 Reportlinker.com announces... its catalogue: ,, United States Dental Device...tp://www.reportlinker.com/p0158733/United-States-D...5.html ,, United States Dental Devices Market ..., This report is an essential source for in-depth...
(Date:11/25/2009)...O, Nov. 25 NuVasive, Inc...ed on developing products for minimally disruptive...y that it will host a conference call on Monday, N... The conference call will focus on current issues ...ts and will include comments from management follo...
(Date:11/25/2009)...ss. and SYDNEY, Nov. 25 ...: HIN), a leading innovator and provider of less i...gies revolutionizing the treatment of advanced hea...o make an investor presentation at the 21st Annual...ST on Wednesday, December 2, 2009. The conference ...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Lexi Comp Inc Receives NorthCoast 99 Honor 55960 1Lexi Comp Inc Receives NorthCoast 99 Honor 55960 2Lexi Comp Inc Receives NorthCoast 99 Honor 55960 3Lexi Comp Inc Receives NorthCoast 99 Honor 55960 4Study Finds Divorce is Bad for Health Divorce Records Website Comments 55957 1Study Finds Divorce is Bad for Health Divorce Records Website Comments 55957 2Cancer Community Alarmed at CMS Policy Lumping Life Saving Cancer Therapy With Diagnostic Testing For Major Funding Cuts 55953 1Cancer Community Alarmed at CMS Policy Lumping Life Saving Cancer Therapy With Diagnostic Testing For Major Funding Cuts 55953 2Cancer Community Alarmed at CMS Policy Lumping Life Saving Cancer Therapy With Diagnostic Testing For Major Funding Cuts 55953 3
...BUSINESS WIRE)--Jun 5, 2007 - Synta,Pharmaceutical...y,focused on discovering, developing, and commerci...al conditions, today announced,encouraging results...or patients in the Company,s double-blind, randomi...ial in metastatic melanoma for its,lead compound, ...
...zes Data Presented at the , 2007 American Society ...ogen(R) Activity in Older Patients with AML and in...ntiation of the molecular interaction of Aloxi(R),...f a Survival Analysis of Glioblastoma Patients,Tre...R) Described-- , --Survival Analysis of Irofulven ...
Other Medicine Technology:Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 2Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 3Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 4Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 5Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 6Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRN...ican professional cycling team dedicated to ethica...ycling champions, announced today that it will bec...ransitions Optical as a new sponsor of the team. T...urer of adaptive eyewear, offering the most advanc...
(Date:11/27/2009)... , SEATTLE, Nov. 27 /PRNewsw...te, received record-high Thanksgiving traffic numb...efore Thanksgiving, providing a clear picture of w...year. The average Thanksgiving meal in 2009 weighe...crease from last year,s feast. According to the Al...
(Date:11/26/2009)... , NEW YORK, Nov. 27 With co...n ever to employ good practices to control the spr...d to be proactive not only to keep ourselves healt...k," said Eileen Finerty, RN, MS, CIC (certified in...n control and occupational health at Hospital for ...
(Date:11/26/2009)...s get a bigger thrill when on an emotional rollerc...6 (HealthDay News) -- Call it the fear factor meet...ts that spectators -- especially those who root fo...ion if it,s a closely contested match and victory ... despair. , Chew on that this Thanksgiving week...
(Date:11/26/2009)... Ennis & Ennis, P.A. is ...s for users of Yaz and Yasmin birth control pills ...lmonary Embolism, Stroke, Heart Attack or other re...ved. Women can call toll free at 1-800-856-6405 or...islaw.com and fill out an online case evaluation ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
... have given birth to babies with eyesight defects....r and water pollution //caused by coal mining in t...dih district, around 200 km from here, were brough...partment. While two babies have no eyeballs, the o...
...ntly been tested in 950 patients with Hormone Refr...e significant improvement in Progression-Free Surv...hase III trial on Satraplatin has shown: * Hig... Prior Chemotherapy Treatment, including Taxotere?...
... Aiming to make a fast buck, a woman made a show o...atment against liver cancer. //She had swindled to...ecurrent liver cancer, as she would have people be...the treatments that she had claimed to undergo. ...
...Australian man gouged out both her eyes with an el...8-year-old woman's partner, a man of around 30 yea...fter the incident. The horrific string of e...s followed by the man chasing down the woman. He a...
...etting closer for the Bush administration and ther...st recent, is the one cited by the American Civil ...he information provided by the federally sponsored...trician at the Mailman School of Public Health at ...
...of successive Australian governments, a report com...that the health of aborigines lags an appalling on...nal and Torres Strait Islander people have signifi...ri the gaps were fewer, smaller and closing, it sa...
Other Medicine News:Health News:Women Deliver Babies With Eye Defects in Jharkhand Villages 2Health News:Satraplatin Benefits Hormone Refractory Prostate Cancer Patients 2Health News:Satraplatin Benefits Hormone Refractory Prostate Cancer Patients 3Health News:Satraplatin Benefits Hormone Refractory Prostate Cancer Patients 4Health News:Satraplatin Benefits Hormone Refractory Prostate Cancer Patients 5Health News:Aborigines Century Behind the Health of Colonizers, WHO Report 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: